Preventive Chemotherapy for Neglected Tropical Diseases | WHO
- Preventive chemotherapy (PC) represents a cornerstone in the global effort to combat neglected tropical diseases (NTDs).
- The World Health Organization (WHO) currently recommends PC as a core intervention against five key NTDs: lymphatic filariasis (LF), onchocerciasis, schistosomiasis, soil-transmitted helminthiases (STH), and trachoma.
- NTDs are a diverse group of parasitic and bacterial infections that affect over a billion people worldwide, primarily in low- and middle-income countries.
Preventive Chemotherapy: A Global Strategy Against Neglected Tropical Diseases
Preventive chemotherapy (PC) represents a cornerstone in the global effort to combat neglected tropical diseases (NTDs). This public health strategy involves the large-scale distribution of safe, quality-assured medicines, either individually or in combination, to entire populations at regular intervals. These interventions are typically delivered through community- and school-based programs, aiming to interrupt disease transmission and alleviate suffering caused by these often-debilitating conditions.
The World Health Organization (WHO) currently recommends PC as a core intervention against five key NTDs: lymphatic filariasis (LF), onchocerciasis, schistosomiasis, soil-transmitted helminthiases (STH), and trachoma. However, the application of PC extends beyond these five, also being utilized – though on a smaller scale – against foodborne trematodiases, taeniasis, and yaws. Data collection and reporting for these latter conditions remain fragmented, hindering a comprehensive assessment of their impact.
What are Neglected Tropical Diseases?
NTDs are a diverse group of parasitic and bacterial infections that affect over a billion people worldwide, primarily in low- and middle-income countries. They often cause chronic disability, impacting health, education, and economic productivity. Unlike diseases that receive significant global attention, NTDs historically have lacked funding and research, hence the term “neglected.”
How Does Preventive Chemotherapy Work?
PC operates on the principle of mass drug administration (MDA). By treating entire populations, even those without apparent symptoms, the prevalence of infection is reduced, breaking the cycle of transmission. This approach is particularly effective for diseases spread through vectors (like mosquitoes or snails) or through direct contact. The medicines used in PC are specifically chosen for their safety and efficacy against the targeted parasites or bacteria.
It’s important to note that PC is rarely a standalone solution. The WHO emphasizes that PC is most effective when implemented alongside other public health interventions. These complementary measures include managing chronic cases and providing support for individuals with disabilities resulting from NTDs, controlling vectors and their intermediate hosts, improving veterinary public health, and ensuring access to safe water, sanitation, and hygiene (WASH) services. These integrated approaches enhance the overall impact of PC, both in terms of controlling disease symptoms and reducing transmission rates.
Global Implementation and Coverage
As of , , 71 countries and territories were actively implementing PC programs for at least one NTD, reaching an estimated 819 million individuals requiring treatment. This represents a significant global effort, however, coverage has seen a slight decrease since , falling from 53.1% to 50.6%.
A significant factor contributing to this decline is a reduction in coverage within India, the country with the highest burden of NTDs requiring PC. While India experienced a decrease of approximately 117 million people treated in compared to , other regions saw an increase in coverage. Excluding India from the analysis, the number of people receiving PC for at least one disease actually increased by nearly 60 million, rising from 402.3 million in to 462.2 million in . In total, over 1.47 billion treatments were delivered globally in .
The Role of WHO and Member States
The WHO plays a crucial coordinating role in the global implementation of PC programs. Member States submit reports on their PC activities using a standardized reporting system, known as the PC Joint Application Package. This system facilitates the application process for medicines, allows for review of interventions, and promotes better coordination and integration among different health programs.
Safety and Integrated Approaches
PC is designed to be a safe intervention, utilizing well-established medicines administered under controlled conditions. However, ongoing monitoring and evaluation are essential to assess the safety and effectiveness of PC programs. The integration of PC with other health interventions – such as individual disease management, vector control, and improved sanitation – is critical for maximizing its impact and achieving long-term control and elimination of NTDs.
The success of PC relies on a collaborative effort involving governments, international organizations, healthcare workers, and communities. By working together, we can continue to make progress towards a world free from the burden of neglected tropical diseases.